Skip to content

Clinical trials

Phase 2 Coronavirus Infections trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Phase: Phase 2 Country / region: Brazil Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20209
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universidade Federal do Rio de Janeiro2
Andrew Eisenberger1
BioNTech SE1
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado1
GlaxoSmithKline1
Instituto do Cancer do Estado de São Paulo1
Max O'Donnell1
Ministry of Health, Brazil1
Tânia Portella Costa1
Universidade Federal de Sao Carlos1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1912
Coronavirus Infections12
Pneumonia2
Severe Acute Respiratory Syndrome2
Angioedemas, Hereditary1
Cytokine Release Syndrome1
Neoplasms1
Pneumonia, Viral1
Respiratory Distress Syndrome1
Respiratory Tract Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.